Li-Fraumeni and Related Syndromes: Correlation Between Tumor Type, Family Structure, and TP53 Genotype
Overview
Authors
Affiliations
A database has been created to collect information on families carrying a germ-line mutation in the TP53 gene and on families affected with Li-Fraumeni syndromes [Li-Fraumeni syndrome (LFS) and Li-Fraumeni-like syndrome (LFL)]. Data from the published literature have been included. The database is available online at http://www.iarc.fr/p53, as part of the IARC TP53 Database. The analysis of the 265 families/individuals that have been included thus far has revealed several new findings. In classical LFS families with a germ-line TP53 mutation (83 families), the mean age of onset of breast cancer was significantly lower than in LFS families (16 families) without a TP53 mutation (34.6 versus 42.5 years; P = 0.0035). In individuals with a TP53 mutation, a correlation between the genotype and phenotype was found. Brain tumors were associated with missense TP53 mutations located in the DNA-binding loop that contact the minor groove of DNA (P = 0.01), whereas adrenal gland carcinomas were associated with missense mutations located in the loops opposing the protein-DNA contact surface (P = 0.003). Finally, mutations likely to result in a null phenotype (absence of the protein or loss of function) were associated with earlier onset brain tumors (P = 0.004). These observations have clinical implications for genetic testing and tumor surveillance in LFS/LFL families.
Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies.
Cardano M, Buscemi G, Zannini L Cells. 2025; 14(5).
PMID: 40072091 PMC: 11898824. DOI: 10.3390/cells14050363.
Galante P, Guardia G, Pisani J, Sandoval R, Barros-Filho M, Gifoni A Lancet Reg Health Am. 2025; 42:100982.
PMID: 39895904 PMC: 11787607. DOI: 10.1016/j.lana.2024.100982.
Decoding the mechanisms behind second primary cancers.
Zeng M, Lin A, Jiang A, Qiu Z, Zhang H, Chen S J Transl Med. 2025; 23(1):115.
PMID: 39856672 PMC: 11762917. DOI: 10.1186/s12967-025-06151-9.
Katsonis P, Lichtarge O Nat Commun. 2025; 16(1):159.
PMID: 39746940 PMC: 11696468. DOI: 10.1038/s41467-024-55066-4.
Bianca Lopes David B, Silva S, Dinoa V, Diniz T, Pereira E, Bustamante C Case Rep Oncol Med. 2024; 2024:6640468.
PMID: 39734593 PMC: 11671632. DOI: 10.1155/crom/6640468.